HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy

• Asıl Yazarlar: Ioannis A. Vathiotis (Yazar), Andriani Charpidou (Yazar), Niki Gavrielatou (Yazar), Konstantinos N. Syrigos (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2021-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

While human epidermal growth factor receptor 2 (HER2) aberrations have long been described in patients with non-small cell lung cancer (NSCLC), they have only recently been effectively targeted. Unlike patients with breast cancer, NSCLC patients can harbor either <i>HER2</i>-activating m...